Main > HEMATOLOGY > USA. C. ITP Chronic>Treat.>Immune>

---

USA. C. ITP Chronic>Treat.>Immune>'s subsections
(*) USA>Approved
>Globulin IV (Human) 10% Liquid
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 06.08.
RTM
RTM USA Web-Site

USA. C. ITP Chronic>Treat.>Immune>'s products
This section has no products